Form 8-K - Current report:
SEC Accession No. 0001104659-25-058892
Filing Date
2025-06-12
Accepted
2025-06-12 16:19:52
Documents
12
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517793d1_8k.htm   iXBRL 8-K 31004
  Complete submission text file 0001104659-25-058892.txt   198365

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zbio-20250610.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zbio-20250610_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zbio-20250610_pre.xml EX-101.PRE 22358
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517793d1_8k_htm.xml XML 3794
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42270 | Film No.: 251042900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)